C
TransMedics Group, Inc. TMDX
$125.74 -$2.76-2.15% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 35.92% 274.54% 62.64% -65.43% -0.02%
Total Depreciation and Amortization 9.68% 8.05% 9.72% 12.57% 6.90%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 0.62% -24.94% 48.72% -0.40% 7.18%
Change in Net Operating Assets 190.51% -661.32% 48.16% -6,455.37% 100.63%
Cash from Operations 3,308.72% -114.52% 186.76% -73.34% 848.70%
Capital Expenditure 66.44% -98.72% 71.77% -102.85% 46.20%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -100.00% -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 66.44% -98.72% 71.51% -100.99% 46.20%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 134.11% 155.31% -84.91% -26.12% 234.10%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 134.11% 155.31% -84.91% -26.12% 234.10%
Foreign Exchange rate Adjustments 125.98% 152.11% -277.98% 722.58% 64.16%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 441.16% -504.32% 120.08% -360.55% 128.11%